Trial Profile
Exploratory trial on intra-articular etanercept treatment in inflammatory arthritis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Aug 2023
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Therapeutic Use
- 14 Nov 2012 Results presented at the 76th Annual Scientific Meeting of the American College of Rheumatology and the 47th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 12 Nov 2012 Primary endpoint 'Improvement-in-symptoms' has been met.
- 26 Feb 2012 Status changed from planning to completed as reported by Netherlands Trial Register.